Replies to post #15702 on Radient Pharmaceuticals Corporation fka RXPC

[jimtash]

It said it expires but according to the patent office, was renewed and current. So obviously they still hold the patent rights to DR-70/Onko Sure. Also says they have 3 more patent applications in the works. You should take your accusations to the Patent Office because it seems they're in collusion with Radient considering they have one thing and you say another.

The U.S. Patent and Trademark Office has issued to us two patents which describe methods for measuring ring-shaped particles in extra-cellular fluid as a means for detecting cancer. Our patent for a method of detecting the tumors using ring shaped particles as a tumor marker was issued on October 17, 1995 and expires on October 17, 2012. Our patent for a method for detecting the presence of ring shaped particles as tumor markers was issued on June 3, 1997 and expires on June 3, 2014. We have three additional patent applications pending in the U.S. with respect to our methodology for the ONKO-SUREtm tumor-markers as reliable indicators of the presence of cancer. In addition, we have one patent based on our methodology for the ONKO-SUREtm tumor marker pending in Europe.